Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEREST: Everolimus in Adjuvant Renal Cancer
NCT01120249Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2011
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of everolimus in renal cell carcinoma (RCC), sponsored by SWOG Cancer Research Network. Started Apr 2011; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01120249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120249.